STARTRK-2: An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectini
- This topic has 0 replies, 1 voice, and was last updated 4 years, 8 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
STARTRK-2: An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors (including cholangiocarcinoma) that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements
https://clinicaltrials.gov/ct2/show/NCT02568267
Gavin
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.